Penn Medicine Provider
Medical Oncology, Hematology
Melina Elpi Marmarelis, MD
5.0
(307)
Accepting new patients
Sees patients age 18 and up
Penn Mesothelioma and Pleural Program
View 1 additional location

About me

  • Medical Director, Penn Mesothelioma Program
  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Harvard Medical School
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

307 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
expert
April 2025
5.0
5.0
she is so good, patience and listening to the patient
April 2025
5.0
5.0
dr marmarelis is very compassionate and knowledgeable
April 2025
5.0
5.0
it was a pleasure to meet with the doctor

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Marmarelis is a Penn Medicine physician.

Qualifications and experience

My research

Benjamin Besse, MD, PhD, Koichi Goto, MD, PhD, Yongsheng Wang, MD, Se-Hoon Lee, MD, PhD, Melina E. Marmarelis, MD, Yuichiro Ohe, MD, PhD, Reyes Bernabe Caro, MD, Dong-Wan Kim, MD, PhD, Jong-Seok Lee, MD, PhD, Sophie Cousin, MD, MSc, Eiki Ichihara, MD, PhD, Yongsheng Li, MD, PhD, Paz-Ares Luis, MD, PhD, Akira Ono, MD, PhD, Rachel E. Sanborn, MD, Naohiro Watanabe, MD, Maria Jose de Miguel, MD, PhD, Carole Helissey, MD, Catherine A. Shu, MD, Alexander Spira, MD, PhD, Pascale Tomasini, MD, MSc, James Chih-Hsin Yang, MD, PhD, Yiping Zhang, MD, Enriqueta Felip, MD, PhD, Frank Griesinger, MD, PhD, Saima N. Waqar, MD, Antonio Calles, MD, Joel Neal, MD, PhD, Christina S. Baik, MD, Pasi A. Jänne, MD, PhD, S. Martin Shreeve, MD, PhD, Joshua C. Curtin, PhD, Bharvin Patel, PhD, Michael Gormley, PhD, Xuesong Lyu, PhD, Jun Chen, MD, MSc, Pei-Ling Chu, PhD, Janine Mahoney, BSN, RN, Leonardo Trani, MD, Joshua M. Bauml, MD, Meena Thayu, MD, MSCE, Roland E. Knoblauch, MD, PhD, Byoung Chul Cho, MD, PhD Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A , J Thorac Oncol, 20(5): 2025,651-664


Adam Barsouk, Omar Elghawy, Alex Watts, Lauren Reed-Guy, William Tompkins, Krishna Chandrasekhara, Connor B. Grady, Wade Iams, Fangdi Sun, Geoffrey Liu, Devalben Patel, Jorge J. Nieva, Kristen A. Marrone, Vamsidhar Velcheti, Stephen V. Liu, Tejas Patil, Jared Weiss, William Schwartzman, Liza C Villaruz, Amanda Hermann, Melina E. Marmarelis Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis , Lung Cancer, 203: 2025,108551


Elghawy O, Barsouk A, Reed-Guy L, Stalker M, Sussman J, Robinson K, Kosteva J, Singh A, Cohen RB, Langer C, Ciunci C, D'Avella C, Sun L, Marmarelis ME, Aggarwal C Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy , Clin Lung Cancer, 26(2): 2025,158-163.e2


Margaret Stalker, Suzanne L. Walker, Emily Lebow, Emily Ling-Lin Pai, Alex Watts, Wei-Ting Hwang, Amir Banihashemi, Evan Anderson, Leonid Roshkovan, Sharyn I. Katz, Leslie Litzky, Andrew R. Haas, Sunil Singhal, Corey J. Langer, Keith Cengel, Melina E. Marmarelis Incidence and outcomes of brain metastasis in pleural mesothelioma in the era of immunotherapy , JTO Clin Res Rep, 6(5): 2025,100823


Lova Sun, Melina E. Marmarelis, Charu Aggarwal Oncology Grand Rounds: Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer , J Clin Oncol, 43(13): 2025,1527-1533


Tejas Patila ∙ Dexiang Gaob ∙ Alexander Watsona ∙ Mandy Sakamotoa ∙ Yunan Niec ∙ Amanda Gibsond ∙ Michelle L Deand ∙ Benjamin A. Yodera ∙ Eliza Millera ∙ Margaret Stalkere ∙ Dara L. Aisnerf ∙ Paul A. Bunna ∙ Erin L. Schenka ∙ Melina E. Marmarelise ∙ Chiara Bennatig ∙ Vishal Navanid ∙ Yongchang Zhangh ∙ D. Ross Camidge The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations , Lung Cancer, 199(108040): 2025


Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, Wei-Ting Hwang, John Kosteva, Michael R Costello, Lova Sun, Aditi P Singh, Kelsey S Lau-Min, Abigail Doucette, Peter E Gabriel, Anthony O Martella, Megan A Roy, Jeffrey C Thompson, Roger B Cohen, David W Dougherty, Lawrence N Shulman, Corey J Langer, Justin E Bekelman, Erica L Carpenter, Charu Aggarwal Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients with Metastatic Non-Small Cell Lung Cancer: Results from a Prospective Clinical Trial , JCO Oncol Pract, 20(12): 2024,1620-1628


Connor B. Grady, Wei-Ting Hwang, Joshua E. Reuss, Wade Iams, Amanda Cass, Geoffrey Liu, Devalben Patel, Stephen V. Liu, Gabriela Liliana Bravo Montenegro, Tejas Patil, Jorge J. Nieva, Amanda Herrmann, Kristen A. Marrone, Vincent K. Lam, William Schwartzman, Jonathan Dowell, Liza C Villaruz, Kelsey Leigh Miller, Jared Weiss, Fangdi Sun, Vamsidhar Velcheti, D. Ross Camidge, Charu Aggarwal, Lova Sun, Melina E. Marmarelis Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer , Pharmacoepidemiology and Drug Safety, 33(12): 2024,e70049.


Stalker M, Grady CB, Watts A, Hwang WT, Chandrasekhara K, Sun F, Liu G, Patel D, Nieva J, Herrmann A, Marrone K, Lam VK, Velcheti V, Liu SV, Bravo Montenegro GL, Tompkins W, Patil T, Weiss J, Miller KL, Schwartzman W, Dowell JE, Shaverdashvili K, Villaruz L, Cass A, Iams W, Aisner D, Aggarwal C, Camidge DR, Sun L, Marmarelis ME. Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis , JTO Clin Res Rep, 6: 2024,100765


Stalker M, Marmarelis M, Langer C, Cohen RB, Singh A, Aggarwal C, Sun L Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC , Clin Lung Cancer, 26(2): 2024,124-130. e1